Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchProton Pump InhibitorsPPIs (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study

Freedberg et al., Gastroenterology, doi:10.1053/j.gastro.2020.05.053
May 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Death/intubation -34% Improvement Relative Risk Proton Pump Inhibitors  Freedberg et al.  Prophylaxis Is prophylaxis with proton pump inhibitors beneficial for COVID-19? PSM retrospective 1,620 patients in the USA Higher death/intubation with proton pump inhibitors (p=0.014) c19early.org Freedberg et al., Gastroenterology, May 2020 FavorsPPIs Favorscontrol 0 0.5 1 1.5 2+
PPIs for COVID-19
1st treatment shown to increase risk in September 2020, now with p = 0.000000048 from 40 studies.
5,300+ studies for 116 treatments. c19early.org
PSM retrospective 1,620 hospitalized patients in the USA, showing higher risk of combined death/intubation with PPI treatment.
Standard of Care (SOC): SOC for COVID-19 in the study country, the USA, is very poor with very low average efficacy for approved treatments1. Only expensive, high-profit treatments were approved. Low-cost treatments were excluded, reducing the probability of treatment—especially early—due to access and cost barriers, and eliminating complementary and synergistic benefits seen with many low-cost treatments.
Study covers proton pump inhibitors and famotidine.
risk of death/intubation, 34.0% higher, HR 1.34, p = 0.01, treatment 8 of 84 (9.5%), control 332 of 1,536 (21.6%), NNT 8.3, adjusted per study, propensity score matching, multivariable, Cox proportional hazards.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Freedberg et al., 21 May 2020, retrospective, propensity score matching, USA, peer-reviewed, 15 authors.
This PaperPPIsAll
DOI record: { "DOI": "10.1053/j.gastro.2020.05.053", "ISSN": [ "0016-5085" ], "URL": "http://dx.doi.org/10.1053/j.gastro.2020.05.053", "alternative-id": [ "S0016508520347065" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study" }, { "label": "Journal Title", "name": "journaltitle", "value": "Gastroenterology" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1053/j.gastro.2020.05.053" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 by the AGA Institute" } ], "author": [ { "ORCID": "http://orcid.org/0000-0003-2023-2899", "affiliation": [], "authenticated-orcid": false, "family": "Freedberg", "given": "Daniel E.", "sequence": "first" }, { "affiliation": [], "family": "Conigliaro", "given": "Joseph", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Timothy C.", "sequence": "additional" }, { "affiliation": [], "family": "Tracey", "given": "Kevin J.", "sequence": "additional" }, { "affiliation": [], "family": "Callahan", "given": "Michael V.", "sequence": "additional" }, { "affiliation": [], "family": "Abrams", "given": "Julian A.", "sequence": "additional" }, { "affiliation": [], "family": "Sobieszczyk", "given": "Magdalena E.", "sequence": "additional" }, { "affiliation": [], "family": "Markowitz", "given": "David D.", "sequence": "additional" }, { "affiliation": [], "family": "Gupta", "given": "Aakriti", "sequence": "additional" }, { "affiliation": [], "family": "O’Donnell", "given": "Max R.", "sequence": "additional" }, { "affiliation": [], "family": "Li", "given": "Jianhua", "sequence": "additional" }, { "affiliation": [], "family": "Tuveson", "given": "David A.", "sequence": "additional" }, { "affiliation": [], "family": "Jin", "given": "Zhezhen", "sequence": "additional" }, { "affiliation": [], "family": "Turner", "given": "William C.", "sequence": "additional" }, { "affiliation": [], "family": "Landry", "given": "Donald W.", "sequence": "additional" } ], "container-title": [ "Gastroenterology" ], "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.jp", "clinicalkey.com", "gastrojournal.org", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 5, 22 ] ], "date-time": "2020-05-22T01:22:26Z", "timestamp": 1590110546000 }, "deposited": { "date-parts": [ [ 2021, 5, 19 ] ], "date-time": "2021-05-19T04:27:01Z", "timestamp": 1621398421000 }, "funder": [ { "DOI": "10.13039/100000002", "doi-asserted-by": "publisher", "name": "National Institutes of Health" } ], "indexed": { "date-parts": [ [ 2022, 1, 19 ] ], "date-time": "2022-01-19T16:47:56Z", "timestamp": 1642610876500 }, "is-referenced-by-count": 130, "issn-type": [ { "type": "print", "value": "0016-5085" } ], "issue": "3", "issued": { "date-parts": [ [ 2020, 9 ] ] }, "journal-issue": { "issue": "3", "published-print": { "date-parts": [ [ 2020, 9 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 9, 1 ] ], "date-time": "2020-09-01T00:00:00Z", "timestamp": 1598918400000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0016508520347065?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0016508520347065?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "1129-1131.e3", "prefix": "10.1053", "published": { "date-parts": [ [ 2020, 9 ] ] }, "published-print": { "date-parts": [ [ 2020, 9 ] ] }, "publisher": "Elsevier BV", "reference": [ { "author": "Gottschlich", "key": "10.1053/j.gastro.2020.05.053_bib1", "series-title": "American Society for Parenteral and Enteral Nutrition", "year": "2007" }, { "DOI": "10.1016/S0024-3205(96)00553-X", "author": "Bourinbaiar", "doi-asserted-by": "crossref", "first-page": "PL365", "journal-title": "Life Sci", "key": "10.1053/j.gastro.2020.05.053_bib2", "volume": "59", "year": "1996" }, { "DOI": "10.1016/j.apsb.2020.02.008", "author": "Wu", "doi-asserted-by": "crossref", "first-page": "766", "journal-title": "Acta Pharm Sin B", "key": "10.1053/j.gastro.2020.05.053_bib3", "volume": "10", "year": "2020" }, { "DOI": "10.1126/science.1085658", "author": "Anand", "doi-asserted-by": "crossref", "first-page": "1763", "journal-title": "Science", "key": "10.1053/j.gastro.2020.05.053_bib4", "volume": "300", "year": "2003" }, { "DOI": "10.1016/j.stem.2017.11.003", "author": "Chen", "doi-asserted-by": "crossref", "first-page": "747", "journal-title": "Cell Stem Cell", "key": "10.1053/j.gastro.2020.05.053_bib5", "volume": "21", "year": "2017" }, { "DOI": "10.1096/fj.202000502", "author": "Li", "doi-asserted-by": "crossref", "first-page": "6008", "journal-title": "FASEB J", "key": "10.1053/j.gastro.2020.05.053_bib6", "volume": "34", "year": "2020" } ], "reference-count": 6, "references-count": 6, "relation": {}, "score": 1, "short-container-title": [ "Gastroenterology" ], "short-title": [], "source": "Crossref", "subject": [ "Gastroenterology", "Hepatology" ], "subtitle": [], "title": [ "Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study" ], "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "159" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit